Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03769194
Recruitment Status : Active, not recruiting
First Posted : December 7, 2018
Last Update Posted : October 1, 2019
Sponsor:
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : October 2020